0001242616-12-000012.txt : 20120529
0001242616-12-000012.hdr.sgml : 20120529
20120529140503
ACCESSION NUMBER: 0001242616-12-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120524
FILED AS OF DATE: 20120529
DATE AS OF CHANGE: 20120529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEIDEN WILLIAM K
CENTRAL INDEX KEY: 0001214939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 12873673
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-05-24
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001214939
HEIDEN WILLIAM K
C/O AMAG PHARMACEUTICALS, INC.
100 HAYDEN AVENUE
LEXINGTON
MA
02421
1
1
0
0
President and CEO
Common Stock
2012-05-24
4
P
0
5000
A
5000
D
Common Stock
2012-05-25
4
P
0
5000
A
10000
D
The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.31-$13.55. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
The shares purchased on this date were purchased in multiple transactions. The actual purchase prices range from $13.77-$13.96. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
Nancy R. Smith, attorney-in-fact
2012-05-29